• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小分子 MDM2 抑制剂 LQFM030 诱导 p53 缺失的 K562 慢性髓系白血病细胞凋亡。

Small-molecule MDM2 inhibitor LQFM030-induced apoptosis in p53-null K562 chronic myeloid leukemia cells.

机构信息

Laboratory of Education and Research in In Vitro Toxicology - Tox In, Faculty of Pharmacy, Universidade Federal de Goiás, Goiânia, 74605-220, Brazil.

Laboratório de Química Farmacêutica Medicinal (LQFM), Faculty of Pharmacy, Universidade Federal de Goiás, Goiânia, 74605-220, Brazil.

出版信息

Fundam Clin Pharmacol. 2020 Aug;34(4):444-457. doi: 10.1111/fcp.12540. Epub 2020 Mar 14.

DOI:10.1111/fcp.12540
PMID:32011031
Abstract

Our group designed and synthesized the N-phenyl-piperazine LQFM030 [1-(4-((1-(4-chlorophenyl)-1H-pyrazol-4-yl)methyl) piperazin-1-yl) ethanone], a small molecule derived from molecular simplification of the Nutlin-1, an inhibitor of the human homologue of murine double minute 2 (MDM2) protein that is expressed in several types of cancer. To better investigate the effects of LQFM030 regarding the p53 mutation status, this study investigated the antiproliferative activity of LQFM030 against the p53-null K562 leukemia cells as well as the cell death pathways involved. In addition, the effects of LQFM030 on the levels of the p53/MDM2 complex were also carried out using 3T3 cells as a p53 wild-type model. Our data suggest that LQFM030 triggered apoptosis in K562 cells via different mechanisms including cell cycle arrest, caspase activation, reduction of mitochondrial activity, decrease in MDM2 expression, and transcriptional modulation of MDMX, p73, MYC, and NF-ĸB. Additionally, it promoted effects in p53/MDM2 binding in p53 wild-type 3T3 cells. Therefore, LQFM030 has antiproliferative effects in cancer cells by a p53 mutation status-independent manner with different signaling pathways. These findings open new perspectives to the treatment of leukemic cells considering the resistance development associated with cancer treatment with conventional cytotoxic drugs.

摘要

我们小组设计并合成了 N- 苯基哌嗪 LQFM030[1-(4-((1-(4- 氯苯基)-1H-吡唑-4-基)甲基)哌嗪-1-基)乙酮],这是一种小分子,来源于 Nutlin-1 的分子简化,Nutlin-1 是一种人源同源物二聚体 2(MDM2)蛋白的抑制剂,在几种类型的癌症中表达。为了更好地研究 LQFM030 对 p53 突变状态的影响,本研究调查了 LQFM030 对 p53 缺失的 K562 白血病细胞的抗增殖活性以及涉及的细胞死亡途径。此外,还使用 3T3 细胞作为 p53 野生型模型,研究了 LQFM030 对 p53/MDM2 复合物水平的影响。我们的数据表明,LQFM030 通过不同的机制触发 K562 细胞凋亡,包括细胞周期停滞、半胱天冬酶激活、线粒体活性降低、MDM2 表达减少以及 MDMX、p73、MYC 和 NF-ĸB 的转录调节。此外,它还促进了 p53 野生型 3T3 细胞中 p53/MDM2 结合的作用。因此,LQFM030 通过不同的信号通路,以 p53 突变状态独立的方式对癌细胞具有抗增殖作用。这些发现为治疗白血病细胞开辟了新的视角,考虑到与传统细胞毒性药物治疗相关的癌症耐药性的发展。

相似文献

1
Small-molecule MDM2 inhibitor LQFM030-induced apoptosis in p53-null K562 chronic myeloid leukemia cells.小分子 MDM2 抑制剂 LQFM030 诱导 p53 缺失的 K562 慢性髓系白血病细胞凋亡。
Fundam Clin Pharmacol. 2020 Aug;34(4):444-457. doi: 10.1111/fcp.12540. Epub 2020 Mar 14.
2
Induction of apoptosis in Ehrlich ascites tumour cells via p53 activation by a novel small-molecule MDM2 inhibitor - LQFM030.新型小分子MDM2抑制剂-LQFM030通过激活p53诱导艾氏腹水瘤细胞凋亡
J Pharm Pharmacol. 2016 Sep;68(9):1143-59. doi: 10.1111/jphp.12573. Epub 2016 Jun 28.
3
The novel anticancer agent JNJ-26854165 is active in chronic myeloid leukemic cells with unmutated BCR/ABL and T315I mutant BCR/ABL through promoting proteosomal degradation of BCR/ABL proteins.新型抗癌药物JNJ-26854165通过促进BCR/ABL蛋白的蛋白酶体降解,对具有未突变BCR/ABL和T315I突变型BCR/ABL的慢性髓性白血病细胞具有活性。
Oncotarget. 2017 Jan 31;8(5):7777-7790. doi: 10.18632/oncotarget.13951.
4
MDM2 antagonist can inhibit tumor growth in hepatocellular carcinoma with different types of p53 in vitro.MDM2 拮抗剂可以在体外抑制不同类型 p53 的肝癌肿瘤生长。
J Gastroenterol Hepatol. 2011 Feb;26(2):371-7. doi: 10.1111/j.1440-1746.2010.06440.x.
5
Toxico-pharmacological evaluations of the small-molecule LQFM166: Inducer of apoptosis and MDM2 antagonist.小分子 LQFM166 的毒理学和药理学评价:凋亡诱导剂和 MDM2 拮抗剂。
Chem Biol Interact. 2018 Sep 25;293:20-27. doi: 10.1016/j.cbi.2018.07.004. Epub 2018 Jul 3.
6
LQFM030 reduced Ehrlich ascites tumor cell proliferation and VEGF levels.LQFM030 降低了艾氏腹水癌细胞的增殖和 VEGF 水平。
Life Sci. 2018 May 15;201:1-8. doi: 10.1016/j.lfs.2017.12.029. Epub 2017 Dec 24.
7
Persistent STAT5-mediated ROS production and involvement of aberrant p53 apoptotic signaling in the resistance of chronic myeloid leukemia to imatinib.持续的 STAT5 介导的 ROS 产生和异常 p53 凋亡信号转导在慢性髓细胞白血病对伊马替尼耐药中的作用。
Int J Mol Med. 2018 Jan;41(1):455-463. doi: 10.3892/ijmm.2017.3205. Epub 2017 Oct 20.
8
Non-genotoxic MDM2 inhibition selectively induces a pro-apoptotic p53 gene signature in chronic lymphocytic leukemia cells.非遗传毒性 MDM2 抑制物选择性诱导慢性淋巴细胞白血病细胞中促凋亡的 p53 基因特征。
Haematologica. 2019 Dec;104(12):2429-2442. doi: 10.3324/haematol.2018.206631. Epub 2019 Apr 19.
9
Elevated MDM2 boosts the apoptotic activity of p53-MDM2 binding inhibitors by facilitating MDMX degradation.升高的MDM2通过促进MDMX降解增强p53-MDM2结合抑制剂的凋亡活性。
Cell Cycle. 2008 Jun 1;7(11):1604-12. doi: 10.4161/cc.7.11.5929. Epub 2008 Mar 17.
10
RITA induces apoptosis in p53-null K562 leukemia cells by inhibiting STAT5, Akt, and NF-κB signaling pathways.RITA 通过抑制 STAT5、Akt 和 NF-κB 信号通路诱导 p53 缺失的 K562 白血病细胞凋亡。
Anticancer Drugs. 2018 Oct;29(9):847-853. doi: 10.1097/CAD.0000000000000651.

引用本文的文献

1
The p53 family member p73 in the regulation of cell stress response.p53 家族成员 p73 在细胞应激反应调控中的作用。
Biol Direct. 2021 Nov 8;16(1):23. doi: 10.1186/s13062-021-00307-5.
2
The roles and regulation of MDM2 and MDMX: it is not just about p53.MDM2 和 MDMX 的作用和调节:不仅仅是关于 p53。
Genes Dev. 2021 May 1;35(9-10):575-601. doi: 10.1101/gad.347872.120. Epub 2021 Apr 22.
3
Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?靶向USP7介导的MDM2/MDMX-p53通路去泛素化用于癌症治疗:我们做到了吗?
Front Cell Dev Biol. 2020 Apr 2;8:233. doi: 10.3389/fcell.2020.00233. eCollection 2020.